Altered nitroxidergic and NMDA receptor-mediated modulation of baroreflex-mediated heart rate in obese Zucker rats

Hypertension Research

Volumn 33, Issue 9, 2010, Pages 932-936

  Chen, Jwo Sheng ^a   Wang, Hui Ju ^a   Chang, Weng Cheng ^b   Jao, Chin Ci ^a   Wu, Bor Tsang ^a   Shyu, Woei Cherng ^a   Lee, Shin Da ^a,c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

Author keywords

baroreceptor; blood pressure; glutamate; heart rate; nitric oxide

Indexed keywords

DEXTROMETHORPHAN; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BRADYCARDIA; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HEART RATE; LEAN BODY WEIGHT; MALE; NEUROMODULATION; NITRERGIC NERVE; NONHUMAN; OBESITY; PARALLEL DESIGN; PRESSORECEPTOR; PRESSORECEPTOR REFLEX; RAT; RECEPTOR SENSITIVITY; SYMPATHETIC REFLEX; WILD TYPE; ZUCKER RAT;

ANIMALS; BAROREFLEX; BLOOD PRESSURE; DEXTROMETHORPHAN; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; HEART RATE; MALE; NG-NITROARGININE METHYL ESTER; NITRERGIC NEURONS; NITRIC OXIDE; OBESITY; PHENYLEPHRINE; RATS; RATS, ZUCKER; RECEPTORS, N-METHYL-D-ASPARTATE; SYMPATHOMIMETICS;

EID: 77956418062     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2010.109     Document Type: Article

References (34)

1. Fan W, Reynolds PJ, Andresen MC. Baroreflex frequency-response characteristics to aortic depressor and carotid sinus nerve stimulation in rats. Am J Physiol 1996; 271: H2218-H2227.
2. Staessen J, Fiocchi R, Fagard R, Hespel P, Amery A. Progressive attenuation of the carotid baroreflex control of blood pressure and heart rate during exercise. Am Heart J 1987; 114: 765-772.
3. Biaggioni I, Whetsell WO, Jobe J, NadeauJH. Baroreflex failure in a patient with central nervous system lesions involving the nucleus tractus solitarii. Hypertension 1994; 23: 491-495.
4. Zanzinger J, Czachurski J, Seller H. Effects of nitric oxide on sympathetic baroreflex transmission in the nucleus tractus solitarii and caudal ventrolateral medulla in cats. Neurosci Lett 1995; 197: 199-202.
5. Grassi G, Dell'Oro R, Facchini A, Quarti Trevano F, Bolla GB, Mancia G. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens 2004; 22: 2363-2369.
6. Del Colle S, Milan A, Caserta M, Dematteis A, Naso D, Mulatero P, Rabbia F, Veglio F. Baroreflex sensitivity is impaired in essential hypertensives with central obesity. J Hum Hypertens 2007; 21: 473-478.
7. Skrapari I, Tentolouris N, Perrea D, Bakoyiannis C, Papazafiropoulou A, Katsilambros N. Baroreflex sensitivity in obesity: relationship with cardiac autonomic nervous system activity. Obesity (Silver Spring) 2007; 15: 1685-1693.
8. Alvarez GE, Davy BM, Ballard TP, Beske SD, Davy KP. Weight loss increases cardiovagal baroreflex function in obese young and older men. Am J Physiol Endocrinol Metab 2005; 289: E665-E669.
9. Beske SD, Alvarez GE, Ballard TP, Davy KP. Reduced cardiovagal baroreflex gain in visceral obesity: implications for the metabolic syndrome. Am J Physiol Heart Circ Physiol 2002; 282: H630-H635.
10. Skrapari I, Tentolouris N, Katsilambros N. Baroreflex function: determinants in healthy subjects and disturbances in diabetes, obesity and metabolic syndrome. Curr Diabetes Rev2006; 2: 329-338.
11. Alonso-Galicia M, Brands MW, Zappe DH, Hall JE. Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity. Hypertension 1996; 28: 1047-1054.
12. Fredersdorf S, Thumann C, Ulucan C, Griese DP, Luchner A, Riegger GA, Kromer EP, Weil J. Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats. Cardiovasc Pathol 2004; 13: 11-19.
13. Schreihofer AM, Mandel DA, Mobley SC, Stepp DW. Impairment of sympathetic baroreceptor reflexes in obese Zucker rats. Am J Physiol Heart Circ Physiol 2007; 293: H2543-H2549.
14. Lee SD, Magalang UJ, Krasney JA, Farkas GA. Opioidergic modulation of ventilatory response to sustained hypoxia in obese Zucker rats. Obes Res 2001; 9: 407-413.
15. Lee SD, Nakano H, Farkas GA. NMDA receptor-mediated modulation of ventilation in obese Zucker rats. Int J Obes Relat Metab Disord 2001; 25: 997-1004. (Pubitemid 32566054)
16. Lee SD, Nakano H, Farkas GA. Adenosinergic modulation of ventilation in obese Zucker rats. Obes Res 2005; 13: 545-555.
17. Lee SD, Nakano H, Farkas GA. GABAergic modulation of ventilation and peak oxygen consumption in obese Zucker rats. J Appl Physiol 2001; 90: 1707-1713. (Pubitemid 32336451)
18. Lee SD, Nakano H, Gosselin LE, Krasney JA, Schlenker EH, Farkas GA. Endogenous opioids modulate ventilation and peak oxygen consumption in obese Zucker rats. Am J Respir Crit Care Med 2000; 162: 1009-1015.
19. Pamidimukkala J, Jandhyala BS. Evaluation of hemodynamics, vascular reactivity and baroreceptor compensation in the insulin resistant Zucker obese rats. Clin Exp Hypertens 1996; 18: 1089-1104.
20. Bunag RD, Barringer DL. Obese Zucker rats, though still normotensive, already have impaired chronotropic baroreflexes. Clin Exp Hypertens A 1988; 10 (Suppl 1): 257-262.
21. Krontoradova K, Honzikova N, Fiser B, Novakova Z, Zavodna E, Hrstkova H, Honzik P. Overweight and decreased baroreflex sensitivity as independent risk factors for hypertension in children, adolescents, and young adults. Physiol Res 2008; 57: 385-391.
22. Potts JT. Inhibitory neurotransmission in the nucleus tractus solitarii: implications for baroreflex resetting during exercise. Exp Physiol 2006; 91: 59-72.
23. Wang JJ, Rong WF, Wang WZ, Zhang L, Yuan WJ. NMDA receptor mechanism involved in arterial baroreflex. Acta Pharmacol Sin 2000; 21: 617-622.
24. Dias AC, Vitela M, Colombari E, Mifflin SW. Nitric oxide modulation of glutamatergic, baroreflex, and cardiopulmonary transmission in the nucleus of the solitary tract. Am J Physiol Heart Circ Physiol 2005; 288: H256-H262.
25. Frigero M, Bonagamba LG, Machado BH. The gain of the baroreflex bradycardia is reduced by microinjection of NMDA receptor antagonists into the nucleus tractus solitarii of awake rats. J Auton Nerv Syst 2000; 79: 28-33.
26. Nakano H, Lee SD, Ray AD, Krasney JA, Farkas GA. Role of nitric oxide in thermo- regulation and hypoxic ventilatory response in obese Zucker rats. Am J Respir Crit Care Med 2001; 164: 437-442.
27. Viard E, Sapru HN. Carotid baroreflex in the rat: role of glutamate receptors in the medial subnucleus of the solitary tract. Neuroscience 2004; 126: 785-794.
28. Ohta H, Li X, Talman WT. Release of glutamate in the nucleus tractus solitarii in response to baroreflex activation in rats. Neuroscience 1996; 74: 29-37.
29. Miyawaki T, Suzuki S, Minson J, Arnolda L, Chalmers J, Llewellyn-Smith I, Pilowsky P. Role of AMPA/kainate receptors in transmission of the sympathetic baroreflex in rat CVLM. Am J Physiol 1997; 272: R800-R812.
30. Somers VK, Mark AL, Abboud FM. Interaction of baroreceptor and chemoreceptor reflex control of sympathetic nerve activity in normal humans. J Clin Invest 1991; 87: 1953-1957.
31. Matsuo I, Hirooka Y, Hironaga K, Eshima K, Shigematsu H, Shihara M, Sakai K, Takeshita A. Glutamate release via NO production evoked by NMDA in the NTS enhances hypotension and bradycardia in vivo. Am J Physiol Regul IntegrComp Physiol 2001; 280: R1285-R1291.
32. Cooper VL, Pearson SB, Bowker CM, Elliott MW, Hainsworth R. Interaction of chemoreceptor and baroreceptor reflexes by hypoxia and hypercapnia-a mechanism for promoting hypertension in obstructive sleep apnoea. J Physiol 2005; 568: 677-687.
33. Heistad DD, Abboud FM, Mark AL, Schmid PG. Interaction of baroreceptor and chemoreceptor reflexes. Modulation of the chemoreceptor reflex by changes in baroreceptor activity. J Clin Invest 1974; 53: 1226-1236.
34. De Ferrari GM, Sanzo A, Bertoletti A, Specchia G, Vanoli E, Schwartz PJ. Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. J Am Coll Cardiol 2007; 50: 2285-2290.